Aarsland D - Search Results

1

Rivastigmine in the treatment of dementia associated with Parkinson's disease: effects on activities of daily living.

Olin JT, Aarsland D, Meng X. Olin JT, et al. Among authors: aarsland d. Dement Geriatr Cogn Disord. 2010;29(6):510-5. doi: 10.1159/000305100. Epub 2010 Jun 5. Dement Geriatr Cogn Disord. 2010. PMID: 20523050 Clinical Trial.

2

Neuropsychological profile of patients with Parkinson's disease without dementia.

Janvin C, Aarsland D, Larsen JP, Hugdahl K. Janvin C, et al. Among authors: aarsland d. Dement Geriatr Cogn Disord. 2003;15(3):126-31. doi: 10.1159/000068483. Dement Geriatr Cogn Disord. 2003. PMID: 12584427

3

Rivastigmine for dementia associated with Parkinson's disease.

Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R. Emre M, et al. Among authors: aarsland d. N Engl J Med. 2004 Dec 9;351(24):2509-18. doi: 10.1056/NEJMoa041470. N Engl J Med. 2004. PMID: 15590953 Free article. Clinical Trial.

4

Familial occurrence of dementia and parkinsonism: a systematic review.

Kurz MW, Schlitter AM, Larsen JP, Ballard C, Aarsland D. Kurz MW, et al. Among authors: aarsland d. Dement Geriatr Cogn Disord. 2006;22(4):288-95. doi: 10.1159/000095159. Epub 2006 Aug 17. Dement Geriatr Cogn Disord. 2006. PMID: 16921239 Free article. Review.

5

Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.

Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu C, Lane R. Burn D, et al. Among authors: aarsland d. Mov Disord. 2006 Nov;21(11):1899-907. doi: 10.1002/mds.21077. Mov Disord. 2006. PMID: 16960863 Clinical Trial.

6

Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates.

Ehrt U, Brønnick K, De Deyn PP, Emre M, Tekin S, Lane R, Aarsland D. Ehrt U, et al. Among authors: aarsland d. Int J Geriatr Psychiatry. 2007 Oct;22(10):980-5. doi: 10.1002/gps.1774. Int J Geriatr Psychiatry. 2007. PMID: 17393542 Clinical Trial.

7

Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia.

Sharp SI, Ballard CG, Ziabreva I, Piggott MA, Perry RH, Perry EK, Aarsland D, Ehrt U, Larsen JP, Francis PT. Sharp SI, et al. Among authors: aarsland d. Dement Geriatr Cogn Disord. 2008;26(4):330-8. doi: 10.1159/000161058. Epub 2008 Oct 8. Dement Geriatr Cogn Disord. 2008. PMID: 18841018

8

Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations.

Cummings J, Emre M, Aarsland D, Tekin S, Dronamraju N, Lane R. Cummings J, et al. Among authors: aarsland d. J Alzheimers Dis. 2010;20(1):301-11. doi: 10.3233/JAD-2010-1362. J Alzheimers Dis. 2010. PMID: 20164585 Free article. Clinical Trial.

9

Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items.

Schmitt FA, Aarsland D, Brønnick KS, Meng X, Tekin S, Olin JT. Schmitt FA, et al. Among authors: aarsland d. Am J Alzheimers Dis Other Demen. 2010 Aug;25(5):407-13. doi: 10.1177/1533317510367486. Epub 2010 Apr 14. Am J Alzheimers Dis Other Demen. 2010. PMID: 20392860 Free PMC article.

10

Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.

Larsson V, Engedal K, Aarsland D, Wattmo C, Minthon L, Londos E. Larsson V, et al. Among authors: aarsland d. Dement Geriatr Cogn Disord. 2011;32(4):227-34. doi: 10.1159/000334523. Epub 2011 Nov 25. Dement Geriatr Cogn Disord. 2011. PMID: 22122992 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

671 results

Search Page

Filters